Literature DB >> 3513344

Characterization of the humoral immune response of the rabbit to antigens of Treponema pallidum after experimental infection and therapy.

S A Lukehart, S A Baker-Zander, S Sell.   

Abstract

The development of IgM and IgG antibody responses to antigenic molecules of Treponema pallidum was examined in intratesticularly and intradermally infected rabbits by use of immunofluorescence (IF) and Western blotting techniques. IgM antibody was first detectable on day 6 following intratesticular infection and reached maximal IF titers during the period of clinical orchitis (days 10-17). IgG reached peak IF titers in the resolution period following clearance of most organisms from the testes (after day 17). Initial IgM antibody responses on day 6 were directed against the 46-, 43-, and 37-kdalton molecules, with reactivity to the 14- and 12-kdalton molecules appearing on day 10. IgG antibody, which was first apparent in the Western blot on day 6, was directed against the 37-kdalton molecule. IgG antibody to the 46-kdalton molecule was first apparent on day 13, and the full spectrum of 22 molecules was recognized on day 31. Curative therapy of intradermally infected rabbits one week after infection resulted in lower IgG antibody titers but did not abrogate the development of humoral responses to all of the major antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3513344     DOI: 10.1097/00007435-198601000-00003

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  12 in total

1.  Contribution of rabbit leukocyte defensins to the host response in experimental syphilis.

Authors:  L A Borenstein; T Ganz; S Sell; R I Lehrer; J N Miller
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 2.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Western immunoblotting with five Treponema pallidum recombinant antigens for serologic diagnosis of syphilis.

Authors:  V Sambri; A Marangoni; C Eyer; C Reichhuber; E Soutschek; M Negosanti; A D'Antuono; R Cevenini
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 4.  Recent trends in the serologic diagnosis of syphilis.

Authors:  Muhammad G Morshed; Ameeta E Singh
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

5.  Expression in Escherichia coli of the 37-kilodalton endoflagellar sheath protein of Treponema pallidum by use of the polymerase chain reaction and a T7 expression system.

Authors:  R D Isaacs; J D Radolf
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

6.  Rapid plasma reagin titer variation in the 2 weeks after syphilis therapy.

Authors:  Katherine M Holman; Mark Wolff; Arlene C Seña; David H Martin; Frieda Behets; Kathleen Van Damme; Peter Leone; Linda McNeil; Meredyth L Gehrig; Edward W Hook
Journal:  Sex Transm Dis       Date:  2012-08       Impact factor: 2.830

7.  Cloning and expression of the major 47-kilodalton surface immunogen of Treponema pallidum in Escherichia coli.

Authors:  M V Norgard; N R Chamberlain; M A Swancutt; M S Goldberg
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

8.  CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis.

Authors:  Brandon T Leader; Charmie Godornes; Wesley C VanVoorhis; Sheila A Lukehart
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

9.  Molecular cloning and DNA sequence analysis of the 37-kilodalton endoflagellar sheath protein gene of Treponema pallidum.

Authors:  R D Isaacs; J H Hanke; L M Guzman-Verduzco; G Newport; N Agabian; M V Norgard; S A Lukehart; J D Radolf
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

Review 10.  Polypeptides of Treponema pallidum: progress toward understanding their structural, functional, and immunologic roles. Treponema Pallidum Polypeptide Research Group.

Authors:  S J Norris
Journal:  Microbiol Rev       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.